BUZZ-Australia's Clinuvel Pharmaceuticals soars on positive study results

Reuters07-05

** Shares of Clinuvel Pharmaceuticals rise as much as 16.7% to A$17.710, posting their biggest intraday pct jump since Aug 31, 2022

** Stock hits highest level since Dec. 11, 2023

** Pharmaceutical co announces results of its afamelanotide study evaluating DNA-repair capacity of afamelanotide on skin of healthy volunteers exposed to UV radiation

** Says results shows afamelanotide can reduce oxidative damage and inflammatory reactions after sun exposure and skin damage

** Says study shows afamelanotide assists DNA repair after UV damage

** Stock down 5.2% YTD as of last close

(Reporting by John Biju in Bengaluru)

((John.Biju@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2449928232?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-07-05 12:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2449928232","market":null,"top_or_hot":-1,"title":"BUZZ-Australia's Clinuvel Pharmaceuticals soars on positive study results","media":"Reuters","content":"<html><body><p>** Shares of Clinuvel Pharmaceuticals    rise as much as 16.7% to A$17.710, posting their biggest intraday pct jump since Aug 31, 2022</p><p>   ** Stock hits highest level since Dec. 11, 2023</p><p>   ** Pharmaceutical co announces results of its afamelanotide study evaluating DNA-repair capacity of afamelanotide on skin of healthy volunteers exposed to UV radiation</p><p>   ** Says results shows afamelanotide can reduce oxidative damage and inflammatory reactions after sun exposure and skin damage</p><p>   ** Says study shows afamelanotide assists DNA repair after UV damage</p><p>   ** Stock down 5.2% YTD as of last close </p><p> (Reporting by John Biju in Bengaluru)</p><p>((John.Biju@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Australia's Clinuvel Pharmaceuticals soars on positive study results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Australia's Clinuvel Pharmaceuticals soars on positive study results\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-05 12:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>** Shares of Clinuvel Pharmaceuticals    rise as much as 16.7% to A$17.710, posting their biggest intraday pct jump since Aug 31, 2022   ** Stock hits highest level since Dec. 11, 2023   ** ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7508","symbol_name":"医药生物股","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2449928232","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2449928232","pubTimestamp":1720152547,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"** Shares of Clinuvel Pharmaceuticals    rise as much as 16.7% to A$17.710, posting their biggest intraday pct jump since Aug 31, 2022   ** Stock hits highest level since Dec. 11, 2023   ** Pharmaceutical co announces results of its afamelanotide study evaluating DNA-repair capacity of afamelanotide on skin of healthy volunteers exposed to UV radiation   ** Says results shows afamelanotide can reduce oxidative damage and inflammatory reactions after sun exposure and skin damage   ** Says study shows afamelanotide assists DNA repair after UV damage   ** Stock down 5.2% YTD as of last close  ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7508":"医药生物股","XJO.AU":"标普/澳交所 200指数","BK7067":"生物科技","XKO.AU":"标普/澳交所 300指数","CUV.AU":"CLINUVEL PHARMACEUTICALS LTD","XAO.AU":"标普/澳交所 普通股指数"},"translate_title":"BUZZ-澳大利亚Clinuvel Pharmaceuticals因积极的研究结果而飙升","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XAO.AU":1,"XJO.AU":1,"XKO.AU":1,"CUV.AU":0.9},"content_text":"** Shares of Clinuvel Pharmaceuticals    rise as much as 16.7% to A$17.710, posting their biggest intraday pct jump since Aug 31, 2022   ** Stock hits highest level since Dec. 11, 2023   ** Pharmaceutical co announces results of its afamelanotide study evaluating DNA-repair capacity of afamelanotide on skin of healthy volunteers exposed to UV radiation   ** Says results shows afamelanotide can reduce oxidative damage and inflammatory reactions after sun exposure and skin damage   ** Says study shows afamelanotide assists DNA repair after UV damage   ** Stock down 5.2% YTD as of last close  (Reporting by John Biju in Bengaluru)((John.Biju@thomsonreuters.com;))","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.28.3","shortVersion":"4.28.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2449928232"}